CD84 as a Prognostic Biomarker and Therapeutic Target in Breast Cancer: Interconnections With PDL1, CD74, and Immune Tolerance Mechanisms

Article Figures & Data

Download figure
Open in new tab
Download powerpoint
Figure 1.
Association between CD84 expression and overall survival in breast cancer. Kaplan–Meier survival curve comparing overall survival (OS) between patients with high versus low CD84 mRNA expression levels. High CD84 expression is associated with significantly lower overall survival (p=0.034).
Download figure
Open in new tab
Download powerpoint
Figure 2.
Prognostic value of the CD84/CD48/VAV1/CTNNB1 combined signature in breast cancer. A) Kaplan–Meier survival analysis showing overall survival (OS) in patients with high vs. low expression of the combined CD84/CD48/VAV1/CTNNB1 signature (p=0.000025). B) Kaplan–Meier survival analysis showing recurrence-free survival (RFS) in patients with high vs. low expression of the same combined signature (p=0.000077).